menu
Factsheet
November 05, 2019

The importance of TMB standardization for diagnostic assays

Standardization of TMB scores by using a common set of reference standards
Tumor Mutational Burden (TMB) is a predictive biomarker for response to immune checkpoint inhibitor therapy. Laboratories routinely measure TMB using a variety of NGS panels, employing different chemistries and informatics algorithms. Standardization of TMB scores by using a common set of reference standards allows for a more direct comparison of results and straightforward interpretation from tests performed in different labs and platforms.

Download our factsheet to learn more.

Related Services:
Tumor Mutational Burden (TMB) Assay for Response to Immunotherapy

TMB assay utilizing whole exome sequencing (WES) methodology and proprietary variant analysis compendium

The standardization of Tumor Mutational Burden (TMB) by alignments to reference standards

Joined by Friends of Cancer Research (Friends)

TMB Standardization by Alignment to Reference Standards

Phase 2 of the Friends of Cancer Research TMB Harmonization Project

Panel-based tumor mutational burden (TMB) analysis of matched tumor and plasma specimens using Illumina’s TruSight Oncology 500 next-generation sequencing assay

AACR 2019 Scientific Poster

Read More